المؤلفون: Urbanska, Edyta M., Grauslund, Morten, Berger, Siv M.S., Costa, Junia C., Koffeldt, Peter R., Sørensen, Jens B., Santoni-Rugiu, Eric

المصدر: Urbanska , E M , Grauslund , M , Berger , S M S , Costa , J C , Koffeldt , P R , Sørensen , J B & Santoni-Rugiu , E 2024 , ' ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report ' , Translational Lung Cancer Research , vol. 13 , no. 9 , pp. 2453-2462 . https://doi.org/10.21037/tlcr-24-439

مصطلحات موضوعية: ALK-rearranged non-small cell lung cancer (ALK-rearranged NSCLC), case report, De novo MET-amplification, intrinsic ALK-tyrosine kinase inhibitor resistance (intrinsic ALK-TKI resistance), tyrosine kinase inhibitor combination (TKI combination)

وصف الملف: application/pdf

الاتاحة: https://researchprofiles.ku.dk/da/publications/alktyrosine-kinase-inhibitor-intrinsic-resistance-due-to-de-novo-metamplification-in-metastatic-alkrearranged-nonsmall-cell-lung-cancer-effectively-treated-by-alectinibcrizotinib-combinationcase-report(b5ab96b5-b7d6-4efb-adf2-71014d99f49e).html
https://doi.org/10.21037/tlcr-24-439
https://curis.ku.dk/ws/files/410080999/90934_PB4_3184_R4.pdf

المؤلفون: Kai‐Cheng Peng, Jun‐Wei Su, Zhi Xie, Han‐Min Wang, Mei‐Mei Fang, Wen‐Feng Li, Yu‐Qing Chen, Xu‐Hui Guan, Jian Su, Hong‐Hong Yan, Xu‐Chao Zhang, Hai‐Yan Tu, Qing Zhou, Hua‐Jun Chen, Yi‐Long Wu, Jin‐Ji Yang

المصدر: Thoracic Cancer, Vol 13, Iss 11, Pp 1619-1630 (2022)

مصطلحات موضوعية: de novo MET amplification, EGFR‐sensitive mutation, non‐small cell lung cancer, patient‐derived organoid, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/82192f83a6d54e8a9200d4bcfce4e18f

المؤلفون: Edyta M. Urbanska, Morten Grauslund, Peter R. Koffeldt, Sarah L. B. Truelsen, Johan O. Löfgren, Junia C. Costa, Linea C. Melchior, Jens B. Sørensen, Eric Santoni-Rugiu

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 17; Pages: 13077

مصطلحات موضوعية: EGFR -mutated NSCLC, EGFR-TKI, acquired MET amplification, de novo MET amplification, Crizotinib, combined targeted therapy

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Oncology; https://dx.doi.org/10.3390/ijms241713077

الاتاحة: https://doi.org/10.3390/ijms241713077

المؤلفون: Ou, Sai-Hong Ignatius, Kwak, Eunice L., Siwak-Tapp, Christina, Dy, Joni, Bergethon, Kristin, Clark, Jeffrey W., Camidge, D. Ross, Solomon, Benjamin J., Maki, Robert G., Bang, Yung-Jue, Kim, Dong-Wan, Christensen, James, Tan, Weiwei, Wilner, Keith D., Salgia, Ravi, Iafrate, A. John

المساهمون: 방영주, Bang, Yung-Jue, Kim, Dong-Wan

مصطلحات موضوعية: Non-small cell lung cancer, De novo MET amplification NSCLC, 18(F)-FDG PET/CT, Crizotinib (PF02341066), MET polysomy, Anaplastic lymphoma kinase (ALK) re-arranged NSCLC

Relation: Journal of Thoracic Oncology, Vol.6 No.5, pp.942-946; 95271; https://hdl.handle.net/10371/165514; 2-s2.0-79955458487; https://www.sciencedirect.com/science/article/pii/S1556086415320177?via%3Dihub; 000289554100015

الاتاحة: https://hdl.handle.net/10371/165514
https://doi.org/10.1097/JTO.0b013e31821528d3
https://www.sciencedirect.com/science/article/pii/S1556086415320177?via%3Dihub

المؤلفون: Jingwen Li, Jian-Lin Xu, Hua Zhong, Shuhui Cao

المصدر: Cancer Biology & Therapy

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Lung Neoplasms, Intrinsic resistance, Biopsy, Met amplification, NSCLC, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Positron Emission Tomography Computed Tomography, EGFR-TKI, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Medicine, Humans, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Pharmacology, biology, Crizotinib, business.industry, Gene Amplification, Proto-Oncogene Proteins c-met, medicine.disease, respiratory tract diseases, De novo MET amplification, ErbB Receptors, intrinsic resistance, Bedside-to-Bench Report, 030104 developmental biology, Oncology, Egfr mutation, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Icotinib, Mutation, Cancer research, biology.protein, Molecular Medicine, EGFR mutation, business, Tyrosine kinase, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1913fe3b0adccfa252cb4c45e89956b
https://pubmed.ncbi.nlm.nih.gov/31131689

المؤلفون: D. Ross Camidge, Dong Wan Kim, James G. Christensen, Sai-Hong Ignatius Ou, Robert G. Maki, Christina Siwak-Tapp, Joni Dy, Eunice L. Kwak, Ravi Salgia, Weiwei Tan, Kristin Bergethon, Jeffrey W. Clark, Benjamin Solomon, Yung-Jue Bang, A. John Iafrate, Keith D. Wilner

المصدر: Journal of Thoracic Oncology. 6(5):942-946

مصطلحات موضوعية: Oncology, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Epithelial-Mesenchymal Transition, Bevacizumab, Pyridines, medicine.drug_class, Antibodies, Monoclonal, Humanized, Deoxycytidine, Carboplatin, MET polysomy, Gefitinib, Crizotinib, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anaplastic lymphoma kinase, Mesenchymal–epithelial transition, Anaplastic Lymphoma Kinase, Receptors, Growth Factor, Crizotinib (PF02341066), Lung cancer, Protein Kinase Inhibitors, Aged, business.industry, 18F-FDG PET/CT, Gene Amplification, Antibodies, Monoclonal, Receptor Protein-Tyrosine Kinases, De novo MET amplification NSCLC, Proto-Oncogene Proteins c-met, medicine.disease, Gemcitabine, MET Exon 14 Skipping Mutation, respiratory tract diseases, ALK inhibitor, Treatment Outcome, Pyrazoles, Anaplastic lymphoma kinase (ALK) re-arranged NSCLC, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8aa4fc3551f78b5f6c72616cb1bc19

المؤلفون: Urbanska, Edyta M., Grauslund, Morten, Koffeldt, Peter R., Truelsen, Sarah L. B., Löfgren, Johan O., Costa, Junia C., Melchior, Linea C., Sørensen, Jens B., Santoni-Rugiu, Eric

المصدر: Urbanska , E M , Grauslund , M , Koffeldt , P R , Truelsen , S L B , Löfgren , J O , Costa , J C , Melchior , L C , Sørensen , J B & Santoni-Rugiu , E 2023 , ' Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC ' , International Journal of Molecular Sciences , vol. 24 , no. 17 , 13077 .

مصطلحات الفهرس: acquired MET amplification, combined targeted therapy, Crizotinib, de novo MET amplification, EGFR-mutated NSCLC, EGFR-TKI, article

URL: https://curis.ku.dk/portal/da/publications/realworld-data-on-combined-egfrtki-and-crizotinib-treatment-for-acquired-and-de-novo-met-amplification-in-patients-with-metastatic-egfrmutated-nsclc(382fcff8-2935-420b-a3c7-a9236334b3b2).html
https://doi.org/10.3390/ijms241713077
https://curis.ku.dk/ws/files/387978500/ijms_24_13077_v2.pdf